Gitnux/Report 2026

Microfluidics Industry Statistics

The global microfluidics market is estimated at $46.9 billion in 2026, explore the figures behind growth, companies and trends.
21Statistics
33Sources
4Sections
1Visuals
14mRead
November 22, 2026Updated
Microfluidics Industry Statistics
Samuel NorbergWritten by Samuel Norberg·Fact-checked by Maya Johansson
Published ·Updated
How this report is researched
01Editorial Scope

Gitnux editors write the brief first: the topic, the inclusion rules, and the frame for what belongs.

02Source Research

Agents search the published record and log every extracted figure back to the passage it came from.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 37 days

01 Industry overview

The microfluidics industry at a glance

The global microfluidics market is estimated at $46.9 billion in 2026 and is expanding as lab-on-a-chip, diagnostics, genomics and organ-on-chip applications gain adoption.

$46.9B[3]
Market size, 2026
12.2%[3]
Forecast CAGR, 2026–2033
42.8%[3]
North America share, 2025
35%[4]
Top-five company share, 2025
Market size
The global microfluidics market was valued at $41.9 billion in 2025 and is estimated at $46.9 billion in 2026. Grand View Research projects the market to reach $105.1 billion by 2033.[3]
Forecast & CAGR
The market is forecast to grow at a 12.2% compound annual growth rate from 2026 to 2033. A separate 2025 estimate from Global Market Insights places the 2026–2034 CAGR at 14.9%, illustrating the range of published forecasts.[3][4]
Market share & regions
North America held 42.8% of global microfluidics revenue in 2025 and was the largest regional market. Asia Pacific is identified as the fastest-growing region during 2026–2033.[3]
Segmentation
Lab-on-a-chip held the largest technology share at 38.71% in 2025, while PDMS accounted for 34.99% of revenue by material. Medical applications generated the largest application contribution in the same year.[3]
Key players & concentration
Global Market Insights identifies Danaher as the leading company with more than 11% market share in 2025. The five leading companies—Danaher, Illumina, Thermo Fisher Scientific, PerkinElmer and Agilent Technologies—collectively held 35% of the market.[4]
Pricing
Microfluidic chip pricing varies widely by material, fabrication method and production volume: paper chips can cost less than $0.10, while commercial glass chips can cost $50–$500 or more. Prototype PDMS chips are typically quoted at $30–$80 each after labor, cleanroom time and mold costs.[12]
Trends, drivers & challenges
Growth is being driven by point-of-care diagnostics, personalized medicine, genomics, drug discovery and organ-on-chip development. Key constraints include high fabrication costs, difficulty scaling prototype processes to volume manufacturing and the need for standardized production and validation.[3][13]
Consumer behavior & competition
Demand is shifting toward decentralized and point-of-care testing because microfluidic platforms use small sample and reagent volumes and can shorten turnaround times. Competition combines large life-science suppliers—including Danaher, Illumina, Thermo Fisher Scientific and Agilent—with specialized diagnostic, genomic and chip-manufacturing companies.[4][3]
M&A
In November 2026, ARCHIMED completed its acquisition of Standard BioTools’ microfluidics business for $5.0 million, with the business renamed Biomark Scientific. The transaction creates a standalone provider focused on genomic workflows using integrated fluidic circuits.[14]
Latest news
The most recent major corporate development identified was the November 3, 2026 completion of ARCHIMED’s acquisition of Standard BioTools’ microfluidics business. The acquired business operates as Biomark Scientific and continues to develop automated PCR, qPCR and NGS library-preparation systems based on proprietary microfluidics.[14]

02 Ranking

Top 10 Companies in the Microfluidics Industry

The leading companies in the microfluidics industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 21, 2026 · Next review December 21, 2026

Verdict

Thermo Fisher Scientific stands out for commercializing microfluidic consumables because it is commercializing next-generation consumables for molecular biology and diagnostic microfluidics, while Agilent Technologies focuses on automated electrophoresis and microfluidics since it reports automated electrophoresis and microfluidics among its life-science technologies.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in microfluidic consumables

    Thermo Fisher Scientific

    US

    Ranked #1 · 9.2 · Microfluidic consumables

    Why we picked it: It commercializes next-generation consumables for molecular biology and diagnostic microfluidics, with an operating margin of 17.4%.

  2. Leader in microfluidic instruments and reagents

    Agilent Technologies

    US

    Ranked #2 · 9.1 · Microfluidic instruments and reagents

    Why we picked it: Automated electrophoresis and microfluidics sit inside its life-science technology set, supported by a 21.3% operating margin in 2025.

  3. Leader in automated microfluidic platforms

    Roche

    CH

    Ranked #3 · 9.1 · Automated microfluidic platforms

    Why we picked it: It operates in microfluidic point-of-care testing, backed by a 19.8% R&D share of revenue in 2025.

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the microfluidics industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Thermo Fisher Scientific

Microfluidic consumables · US

9.2
2

Agilent Technologies

Microfluidic instruments and reagents · US

9.1
3

Roche

Automated microfluidic platforms · CH

9.1
4

Illumina

Microfluidic consumables · US

9.0
5

QIAGEN

Automated microfluidic platforms · NL

9.0
6

Hesperos

Multi-organ microfluidic systems · US

8.7
7

Elveflow

Microfluidic flow control instruments · FR

8.6
8

10x Genomics

Single-cell droplet microfluidics · US

8.4
9

Danaher

Diagnostics and life-science microfluidics · US

8.4
10

Bio-Rad Laboratories

Droplet microfluidics and digital PCR · US

8.3

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 21, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Samuel Norberg. (2026, November 21). Top 10 companies in the microfluidics industry. In Microfluidics Industry Statistics. Gitnux. https://gitnux.org/microfluidics-industry-statistics/#top-companies

report visual · Comparison

Bio-MEMS and microfluidics market share by region

North America holds the largest share at 40.2%.

North America40.2%
Europe28.1%
Asia Pacific23.8%
Latin America5%
Middle East and Africa3%
source-verifiedpmarketresearch.com

04 Statistics

Technology

Patent activity stays measurable but uneven: 28,212 micro- and mesofluidics patents were identified across approximately 2015–2024, with the 2024 complete-year record count down to 60.

R&D, patents and design rights in the microfluidics industry

  • 28,212 patents were identified in a micro- and mesofluidics patent search covering approximately 2015–2024; the source uses patent records rather than a formal industry classification.[1]
  • 60 complete-year published patent records were identified for lab-on-a-chip and microfluidics in 2024, down 18% from 73 records in 2021.[2]
  • 49.3% of 28,212 micro- and mesofluidics patents in the study were filed in the United States, equal to 12,995 records.[1]

05 Statistics

Market Intelligence

Revenue baselines are split across different market definitions in 2025, while 2026–2033 growth remains forecast at 12.2% CAGR to reach $105.1 billion by 2033.

Market size, volume and shipments in the microfluidics industry

  • US$41.9 billion was the global microfluidics market value in 2025, measured as revenue across product, technology, material, application and regional segments.[3]
  • US$35.9 billion was the global microfluidics market value in 2025, covering microfluidics devices and components across medical and non-medical applications.[4]
  • US$10.33 billion was the global microfluidics market value in 2025, covering the publisher’s microfluidics industry definition across diagnostic, research and therapeutic applications.[5]
  • US$42.71 billion was the global microfluidics market value in 2025, covering microfluidics-based devices and components across medical and non-medical applications.[6]
  • US$24.15 billion was the global microfluidics market value in 2025, covering microfluidic components and devices across applications, materials and regions.[7]
  • US$24.96 billion was the global microfluidics market value in 2025, covering microfluidics-based devices and components across diagnostics, research and therapeutics; MarketsandMarkets reports revenue, not physical shipments.[8]

Forecast growth and shipments in the microfluidics industry

  • The global microfluidics market is projected to reach US$46.13 billion by 2031 from US$26.90 billion in 2026, implying an 11.39% CAGR over 2026–2031.[7]
  • The global microfluidics market is projected to reach US$20.73 billion by 2030 from US$11.89 billion in 2026, implying a 14.9% CAGR over 2026–2030.[5]
  • The global microfluidics market is projected to reach US$124.2 billion by 2034 from US$40.9 billion in 2026, implying a 14.9% CAGR over 2026–2034.[4]
  • The global microfluidics market is projected to reach US$37.19 billion by 2030 from US$24.96 billion in 2025, implying an 8.3% CAGR over 2025–2030.[8]
  • The global microfluidics market is projected to reach US$122.35 billion by 2034 from US$48.01 billion in 2026, implying a 12.40% CAGR over 2026–2034.[6]
  • The global microfluidics market is projected to reach US$105.1 billion by 2033 from US$46.9 billion in 2026, implying a 12.2% CAGR over 2026–2033.[3]

06 Statistics

Product & Standards

Material mix matters for evaluation: polymers represented 45.7% of global microfluidics market revenue in 2025, while glass and silicon contributed 21.3% and 16.2% to microfluidic-systems revenue.

Materials, inputs and substitution in microfluidics

  • Polymers represented 45.7% of global microfluidics market revenue in 2025, covering polymer-based microfluidic devices and systems by material.[9]
  • Glass represented 21.3% of global microfluidic-systems market revenue in 2025, measured as the glass material segment.[10]
  • Silicon represented 16.2% of global microfluidic-systems market revenue in 2025, measured as the silicon material segment.[10]

07 Statistics

Customers & Channel

Channel spend is consumables-heavy: microfluidic consumables generated 66.7% of global microfluidics market value in 2025, while 36.5% came from chips and cartridges in 2024.

Demand by end use for microfluidics

  • 36.5% of global microfluidics market value came from microfluidic chips and cartridges in 2024; the publisher defines the category as chips and cartridges used in lab-on-a-chip, point-of-care diagnostics and screening.[4]
  • Clinical diagnostics represented approximately 40% of the global digital microfluidics systems-on-a-chip market by application in 2024; this narrower category covers digital microfluidic systems rather than all microfluidics.[11]
  • 66.7% of global microfluidics market value came from microfluidic consumables in 2025, including disposable chips, cartridges, plates, sequencing flow cells, integrated fluidic circuits, diagnostic cards and organ-on-chip plates.[9]

Key questions about the microfluidics industry

What is the size of the microfluidics market in 2026?
The global microfluidics market is estimated at $46.9 billion in 2026.
How fast is the microfluidics market growing from 2026 to 2033?
The market is forecast to grow at a 12.2% compound annual growth rate from 2026 to 2033.
Which companies lead the microfluidics industry?
Thermo Fisher Scientific stands out for commercializing microfluidic consumables because it is commercializing next-generation consumables for molecular biology and diagnostic microfluidics, while Agilent Technologies focuses on automated electrophoresis and microfluidics since it reports automated electrophoresis and microfluidics among its life-science technologies.
What technology area is taking the largest share of microfluidics revenue?
Lab-on-a-chip held the largest technology share at 38.71% in 2025.
Which customer spend dominates in microfluidics in 2025?
Microfluidic consumables accounted for 66.7% of global microfluidics market value in 2025.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, November 21). Microfluidics Industry Statistics. Gitnux. https://gitnux.org/microfluidics-industry-statistics
MLA
Samuel Norberg. "Microfluidics Industry Statistics." Gitnux, 21 Nov 2026, https://gitnux.org/microfluidics-industry-statistics.
Chicago
Samuel Norberg. 2026. "Microfluidics Industry Statistics." Gitnux. https://gitnux.org/microfluidics-industry-statistics.